CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Net sales	$ 3,616,355	$ 2,592,596
Cost of sales	1,280,406	964,951
Gross profit	2,335,949	1,627,645
Operating Expenses
Research and development	61,246	77,475
Sales and marketing	756,233	682,679
General and administrative	1,158,279	1,364,745
Depreciation and amortization	254,776	240,025
TOTAL OPERATING EXPENSES	2,230,534	2,364,924
OPERATING INCOME (LOSS)	105,415	(737,279)
NON-OPERATING INCOME (EXPENSE)
Gain on sale of Investment in GlamSmile Asia Ltd. (Note 3)	0	1,582,597
Equity income from investments	106,663	156,620
Interest expense	(75,060)	(129,985)
Other expense	(35,975)	(449,363)
Other income	63,000	101,918
TOTAL OTHER INCOME	58,628	1,261,787
PROFIT (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	164,043	524,508
Income tax expense	30,565	0
NET INCOME BEFORE NON-CONTROLLING INTEREST	133,478	524,508
NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTEREST	(28,319)	0
NET INCOME ATTRIBUTABLE TO REMEDENT INC. COMMON SHAREHOLDERS	$ 105,159	$ 524,508
PROFIT (LOSS) PER SHARE
Basic (in dollars per share)	$ 0.01	$ 0.03
Fully diluted (in dollars per share)	$ 0.01	$ 0.03
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic (in shares)	19,995,969	19,995,969
Fully diluted (in shares)	19,995,969	19,995,969